Ultra-pressure liquid chromatography/tandem mass spectrometry targeted profiling of arachidonic acid and eicosanoids in human colorectal cancer

Rapid Communications in Mass Spectrometry

Volumn 25, Issue 6, 2011, Pages 755-764

  Mal, Mainak ^a   Koh, Poh Koon ^b   Cheah, Peh Yean ^b   Chan, Eric Chun Yong ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; DISEASES; DRUG PRODUCTS; ELECTROSPRAY IONIZATION; ETHYLENE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; ORGANIC SOLVENTS; UNSATURATED FATTY ACIDS;

ACID SOLVENTS; ARACHIDONIC ACIDS; CUMULATIVE EVIDENCE; EICOSANOIDS; HUMAN COLON; LEUKOTRIEN; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; MULTIPLE REACTION MONITORING; UPLC-MS/MS;

FORMIC ACID;

EID: 79951888262     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.4926     Document Type: Article

References (47)

1. J. Terzic, S. Grivennikov, E. Karin, M. Karin. Inflammation and colon cancer. Gastroenterology 2010, 138, 2101.
2. S. Kraus, N. Arber. Inflammation and colorectal cancer. Curr. Opin. Pharmacol. 2009, 9, 405.
3. L. M. Coussens, Z. Werb. Inflammation and cancer. Nature 2002, 420, 860.
4. A. Mantovani, P. Allavena, A. Sica, F. Balkwill. Cancer-related inflammation. Nature 2008, 454, 436.
5. W. E. Smalley, R. N. DuBois. Colorectal cancer and nonsteroidal anti-inflammatory drugs. Adv. Pharmacol. 1997, 39, 1.
6. A. T. Chan, E. L. Giovannucci, J. A. Meyerhardt, E. S. Schernhammer, G. C. Curhan, C. S. Fuchs. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. J. Am. Med. Assn. 2005, 294, 914.
7. H. Sano, Y. Kawahito, R. L. Wilder, A. Hashiramoto, S. Mukai, K. Asai, S. Kimura, H. Kato, M. Kondo, T. Hla. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 1995, 55, 3785.
8. R. A. Soslow, A. J. Dannenberg, D. Rush, B. M. Woerner, K. N. Khan, J. Masferrer, A. T. Koki. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 2000, 89, 2637.
9. K. Kashfi, B. Rigas. Is COX-2 a 'collateral' target in cancer prevention? Biochem. Soc. Trans. 2005, 33, 724.
10. L. T. Soumaoro, S. Iida, H. Uetake, M. Ishiguro, Y. Takagi, T. Higuchi, M. Yasuno, M. Enomoto, K. Sugihara. Expression of 5-lipoxygenase in human colorectal cancer. World J. Gastroenterol. 2006, 12, 6355.
11. L. G. Melstrom, D. J. Bentrem, M. R. Salabat, T. J. Kennedy, X. Z. Ding, M. Strouch, S. M. Rao, R. C. Witt, C. A. Ternent, M. S. Talamonti, R. H. Bell, T. A. Adrian. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model. Clin. Cancer Res. 2008, 14, 6525.
12. V. E. Steele, C. A. Holmes, E. T. Hawk, L. Kopelovich, R. A. Lubet, J. A. Crowell, C. C. Sigman, G. J. Kelloff. Lipoxygenase inhibitors as potential cancer chemopreventives. Cancer Epidemiol. Biomarkers Prev. 1999, 8, 467.
13. D. Wang, R. N. DuBois. Pro-inflammatory prostaglandins and progression of colorectal cancer. Cancer Lett. 2008, 267, 197.
14. D. Wang, R. N. Dubois. The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 2010, 29, 781.
15. S. Nicosia, T. Vigano, G. C. Folco. Eicosanoids in allergic reactions: quantitative determination by enzyme immunoassay. Pharmacol. Res. 1992, 26 Suppl 2, 116.
16. B. Rigas, I. S. Goldman, L. Levine. Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med. 1993, 122, 518.
17. L. Levine, in Manual of Clinical Laboratory Immunology, (Eds: J. L. Fahey, H. Friedman, N. R. Rose). American Society for Microbiology, Washington DC, 1986.
18. L. Levine. Radioimmunoassay for leukotrienes: some applications and limitations. Adv. Prostaglandin Thromboxane Leukot. Res. 1986, 16, 339.
19. A. Rigas, L. Levine. Arachidonic acid metabolism by rat liver cells (the C-9 cell line). J. Pharmacol. Exp. Ther. 1984, 231, 230.
20. W. C. Hubbard, C. L. Litterst, M. C. Liu, E. R. Bleecker, J. C. Eggleston, T. L. McLemore, M. R. Boyd. Profiling of prostaglandin biosynthesis in biopsy fragments of human lung carcinomas and normal human lung by capillary gas chromatography-negative ion chemical ionization mass spectrometry. Prostaglandins 1986, 32, 889.
21. D. Tsikas. Application of gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry to assess in vivo synthesis of prostaglandins, thromboxane, leukotrienes, isoprostanes and related compounds in humans. J. Chromatogr. B Biomed. Sci. Appl. 1998, 717, 201.
22. H. Tsukamoto, T. Hishinuma, T. Mikkaichi, H. Nakamura, T. Yamazaki, Y. Tomioka, M. Mizugaki. Simultaneous quantification of prostaglandins, isoprostane and thromboxane in cell-cultured medium using gas chromatographymass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2002, 774, 205.
23. F. Catella, J. A. Lawson, D. J. Fitzgerald, G. A. FitzGerald. Endogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertension. Proc. Natl. Acad. Sci. USA 1990, 87, 5893.
24. J. Capdevila, N. Chacos, J. Werringloer, R. A. Prough, R. W. Estabrook. Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid. Proc. Natl. Acad. Sci. USA 1981, 78, 5362.
25. J. Capdevila, S. Wei, J. Yan, A. Karara, H. R. Jacobson, J. R. Falck, F. P. Guengerich, R. N. DuBois. Cytochrome P-450 arachidonic acid epoxygenase. Regulatory control of the renal epoxygenase by dietary salt loading. J. Biol. Chem. 1992, 267, 21720.
26. V. A. Vandernoot, M. VanRollins. Capillary electrophoresis of cytochrome P-450 epoxygenase metabolites of arachidonic acid. 2. Resolution of stereoisomers. Anal. Chem. 2002, 74, 5866.
27. K. Nithipatikom, P. F. Pratt, W. B. Campbell. Determination of EETs using microbore liquid chromatography with fluorescence detection. Am. J. Physiol. Heart Circ. Physiol. 2000, 279, H857.
28. K. G. Maier, L. Henderson, J. Narayanan, M. Alonso-Galicia, J. R. Falck, R. J. Roman. Fluorescent HPLC assay for 20-HETE and other P-450 metabolites of arachidonic acid. Am. J. Physiol. Heart Circ. Physiol. 2000, 279, H863.
29. H. Yue, K. I. Strauss, M. R. Borenstein, M. F. Barbe, L. J. Rossi, S. A. Jansen. Determination of bioactive eicosanoids in brain tissue by a sensitive reversed-phase liquid chromatographic method with fluorescence detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2004, 803, 267.
30. C. A. Bolcato, R. F. Frye, M. A. Zemaitis, S. M. Poloyac. Determination of 20-hydroxyeicosatetraenoic acid in microsomal incubates using high-performance liquid chromatography-mass spectrometry (HPLC-MS). J. Chromatogr. B Analyt. Technol. Biomed. Life. Sci. 2003, 794, 363.
31. M. Takabatake, T. Hishinuma, N. Suzuki, S. Chiba, H. Tsukamoto, H. Nakamura, T. Saga, Y. Tomioka, A. Kurose, T. Sawai, M. Mizugaki. Simultaneous quantification of prostaglandins in human synovial cell-cultured medium using liquid chromatography/tandem mass spectrometry. Prostaglandins Leukot. Essent. Fatty Acids 2002, 67, 51.
32. A. Margalit, K. L. Duffin, P. C. Isakson. Rapid quantitation of a large scope of eicosanoids in two models of inflammation: development of an electrospray and tandem mass spectrometry method and application to biological studies. Anal. Biochem. 1996, 235, 73.
33. H. Yue, S. A. Jansen, K. I. Strauss, M. R. Borenstein, M. F. Barbe, L. J. Rossi, E. Murphy. A liquid chromatography/mass spectrometric method for simultaneous analysis of arachidonic acid and its endogenous eicosanoid metabolites prostaglandins, dihydroxyeicosatrienoic acids, hydroxyeicosatetraenoic acids, and epoxyeicosatrienoic acids in rat brain tissue. J. Pharm. Biomed. Anal. 2007, 43, 1122.
34. P. Yang, D. Chan, E. Felix, T. Madden, R. D. Klein, I. Shureiqi, X. Chen, A. J. Dannenberg, R. A. Newman. Determination of endogenous tissue inflammation profiles by LC/MS/MS: COX- and LOX-derived bioactive lipids. Prostaglandins Leukot. Essent. Fatty Acids 2006, 75, 385.
35. E. C. Kempen, P. Yang, E. Felix, T. Madden, R. A. Newman. Simultaneous quantification of arachidonic acid metabolites in cultured tumor cells using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Anal. Biochem. 2001, 297, 183.
36. T. Hishinuma, K. Suzuki, M. Saito, H. Yamaguchi, N. Suzuki, Y. Tomioka, I. Kaneko, M. Ono, J. Goto. Simultaneous quantification of seven prostanoids using liquid chromatography/tandem mass spectrometry: the effects of arachidonic acid on prostanoid production in mouse bone marrow-derived mast cells. Prostaglandins Leukot. Essent. Fatty Acids 2007, 76, 321.
37. S. Pugh, G. A. Thomas. Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2. Gut 1994, 35, 675.
38. A. Bennett, A. Civier, C. N. Hensby, P. B. Melhuish, I. F. Stamford. Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues. Gut 1987, 28, 315.
39. V. W. Yang, J. M. Shields, S. R. Hamilton, E. W. Spannhake, W. C. Hubbard, L. M. Hylind, C. R. Robinson, F. M. Giardiello. Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis. Cancer Res. 1998, 58, 1750.
40. F. M. Giardiello, E. W. Spannhake, R. N. DuBois, L. M. Hylind, C. R. Robinson, W. C. Hubbard, S. R. Hamilton, V. W. Yang. Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis. Dig. Dis. Sci. 1998, 43, 311.
41. H. Ikawa, H. Kamitani, B. F. Calvo, J. F. Foley, T. E. Eling. Expression of 15-lipoxygenase-1 in human colorectal cancer. Cancer Res. 1999, 59, 360.
42. I. Shureiqi, K. J. Wojno, J. A. Poore, R. G. Reddy, M. J. Moussalli, S. A. Spindler, J. K. Greenson, D. Normolle, A. A. Hasan, T. S. Lawrence, D. E. Brenner. Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers. Carcinogenesis 1999, 20, 1985.
43. I. Shureiqi, S. M. Lippman. Lipoxygenase modulation to reverse carcinogenesis. Cancer Res. 2001, 61, 6307.
44. FDA, US Department of Health and Human Services. Guidance for industry: bioanalytical method validation, 2001.
45. International Conference on Harmonization (ICH). Validation of analytical methods: definitions and terminology. ICH Q2 A, Geneva, 1994.
46. International Conference on Harmonization (ICH). Validation of analytical methods: methodology. ICH Q2 B, Geneva, 1996.
47. C. Bottcher, E. V. Roepenack-Lahaye, E. Willscher, D. Scheel, S. Clemens. Evaluation of matrix effects in metabolite profiling based on capillary liquid chromatography electrospray ionization quadrupole time-of-flight mass spectrometry. Anal. Chem. 2007, 79, 1507.